Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Dougie/The.Italian
I suspect the China syndrome is progressing as expected and I am sitting in anticipation of an early call to say they have submitted the NDA, however. The FDA Phase 3 cannot progress without an injection of cash which is why they have gone for the SPA in the hopes it may convince a US licensee to commit, however. Given all the jam tomorrow put out by the company before regarding the FDA approval process, I'm not going to hold my breath and now don't expect approval till more likely the end of 2026/beginning of 2027 (best forgotten about at the moment, what a disaster it has been).
The European income will be next to nothing given the manufacturer is only issuing 30k cans every 3 months which will be sold at around 40Euros/can (180k GBP to ERP based on 15%), so China is the place for me....lol
Interestingly, JG thinks the FDA phase III study is completed, according to the April 17th Operational update.
Jamie Gibson, CEO of the Group, said “We are delighted with these highly significant and positive results from the Phase 3 clinical study in China, which reinforces the results from the European and US Phase 3 clinical studies".
OMG.....:-O they've been lying to us all along !!!
I see DVP has taken off again, up over 7% today. Market cap at around 625mill AU$ now.
Morning The.Italian,
Interestingly I have been following the antics of CTAG over the years who were also delisted. (not sure if you know of them).
Anyway, a lot of disgruntled shareholders since it was delisted about 5 years ago, although I kept watching since the CEO appeared to have gone AWAL and run off with shareholder money. He did manage to get some remaining investors to part with money after the event which made them even more disgruntled. There were also many unsavory characters on the BB, but I wont go into too much detail on them.
What is interesting is CTAG had an all singin', all dancing wrist band that was supposed to tell the wearer all sorts of
health things. Suffice to say it never took off, however. Apparently, the CEO has now supposedly sold the IP for an alleged 275mill squid to some company (the IP actually has some similarities to those of DLI). I'm still watching as the remaining disgruntled shareholders are now hopeful they will see the light at the end of the tunnel. Good luck to them, if they do.
Of interest since the DLI software would seem to be more advanced and could indicate some light at the end of the DLI tunnel.... :-)
And anyone else who may be interested.
LSE have said "Delisted companies not showing is a temporary glitch that should be resolved soon".
The.Italian try this link:
https://www.lse.co.uk/SharePrice.html?shareprice=PLE
Seems to work. :-)
LSE have said "Delisted companies not showing is a temporary glitch that should be resolved soon".
Try this link: https://www.lse.co.uk/SharePrice.html?shareprice=PLE
Seems to work
Seems there maybe a problem with the PLE BB ?
This is a test.
Afternoon The.Italian,
Well, they have just awarded options to deep longevity employees although I’m not sure why since they still have not sold anything to anyone…….
Yet in the announcement on 29th March 2023 they state.
Based on the FDA's published target review period guidelines which includes time to review the newly provided information, the Board continue to anticipate grant of the De Novo request in Q2 2023.
So, actually anytime from now until the end of June.
Although they have recently employed that local HK director, so maybe not as ominous as I’m alluding to :-)
And you may be right regarding volatility etc given that FUM only has 293mill shares in issue and the sp has not been as volatile as one could expect.
Morning The.Italian,
I appreciate the feedback. It is really difficult to understand what they intend to do but it certainly doesn’t feel right. So much for their ideals of becoming one of the largest pharma companies in HK. In fact it just highlights even more to the locals what a bunch of clowns they truly are.
I wonder if they want to return to their roots as a mining investment company given they may have now realised they are out of their depth regarding pharma…….. lol
And remember, the consolidation after the PLE takeover was only 10:1 from 15 billion shares to 1.5billion, which I consider a more reasonable. Why didn't they consolidate at 20:1 back then when there were 3 times more shares in circulation !!!
One more point.....
If there will only be 228,345,953.75 shares after the consolidation, does this leave the door open allowing the company to issue a shti load of shares to II's who will want a piece of the pie at a preferential price and not buying on the open market for obvious reasons ????
I've been thinking a little more about the 20:1 share consolidation and why they would want to consolidate by so much when it makes no sense, especially now when liquidity will surely be important as news is released.
Initially one of the main reasons they gave for moving to the HK market was because there would be more liquidity, but surely by reducing the shares by 20 to 1 (result = 228,345,953.75 shares) would have the opposite effect and reduce liquidity due to the number of free shares available. Also, surely with less shares available wouldn't the sp become much more volatile in nature ? Given they have stated on numerous occasions that either money would be either returned to shareholders or a shareholder buyback scheme could occur, the latter being utterly stupid now considering the few shares that would subsequently be in circulation, does this not then pose the question that the company must be up to something which I am sure will not be beneficial to shareholders.
Also, I am still confused about how they have tabulated the number of shares as per the tabulations in the DLI takeover (ref announcement sept 2nd 2020 page 13) and those tabulated in the recent rights issue(ref announcement Jan 11th 2023 page 3). Given who have been listed, It would seem the 4 parties involved as the investors of DLI (Zavoronkovs, Insilico C and IP, Other parties [whoever these are]) now appear to be wrapped up under PI's since. PIs were holding 60% of the shares after the DLI takeover (at 1,372,940,120 shares) and were holding 75% before the rights issue. (1,372,940,120 after DLI to 1,796,554,466 just before the Rights issue) the difference is approx. 422, 687,680 shares being those held by the 4 DLI investors above and approx. 9% (being half of their original 18%). Why is the company now listing them as PI's when companies are involved and they are all individual significant shareholders ? And of course, as I noted before, why don't they appear to have taken up their rights since only 37mill shares were taken up by PI's which apparently "A total of 18 valid applications had been received for a total of 596,860,148 Rights Shares". 6 of which are part of the consortium contributing 482,599,542 shares which leaves 114,260,606 shares unaccounted for which is less than half of the 422,687,680 shares held by the 4 and considering there were 12 - 4 = 8 others PIs that must have taken up shares, indicating it could be even less. does this also indicate something is going on ???
Anyone else have any concerns as to what appears to be things going on in the background ??? Or are my figures all wrong and I need lessons in Maths/Accounting ???
Mmmm. I may be wrong, but it looks like the company maybe taking steps with respect to the Chinese approval and eventual income stream process by appointing a HK director with accounting experience who also has fingers in other listed company pies on the HK stock exchange. A good sign ?
Up 26% at close which is not 3 bad, although it still is only 12.5% of the recent 50% drop. That said, the recent update, although not mind blowing, did indicate the Chinese are steaming ahead since they released very positive data results. This could indicate a submission sooner rather than later, hence the buying spree today. They just can’t get hold of those little share certificates…. :-)
A nice rise today (currently 17.78%) on only 2.37mill shares. Certainly an indication that there are now fewer shares in circulation. I’m sure when news is released of the China submission a nice rise will take place followed by a long trend upwards as the countdown to approval ticks down. I also feel the approval may be granted sooner rather than later.
Although I posted FUM as off topic, I was also thinking that maybe it could be used in combination with Fortacin, however. In hindsight, it may not be possible since FUMs gel is rubbed on to the glans of the meat which our product would then desensitise and therefore could be better suited alongside oral drugs like Viagra etc. (not sure if applying our product after the effects of FUMs gel have taken place would work though?)